The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Nanotechnology-based drug delivery systems
Open accessAbstract
Nanoparticles hold tremendous potential as an effective drug delivery system. In this review we discussed recent developments in nanotechnology for drug delivery. To overcome the problems of gene and drug delivery, nanotechnology has gained interest in recent years. Nanosystems with different compositions and biological properties have been extensively investigated for drug and gene delivery applications. To achieve efficient drug delivery it is important to understand the interactions of nanomaterials with the biological environment, targeting cell-surface receptors, drug release, multiple drug administration, stability of therapeutic agents and molecular mechanisms of cell signalling involved in pathobiology of the disease under consideration. Several anti-cancer drugs including paclitaxel, doxorubicin, 5-fluorouracil and dexamethasone have been successfully formulated using nanomaterials. Quantom dots, chitosan, Polylactic/glycolic acid (PLGA) and PLGA-based nanoparticles have also been used for in vitro RNAi delivery. Brain cancer is one of the most difficult malignancies to detect and treat mainly because of the difficulty in getting imaging and therapeutic agents past the blood-brain barrier and into the brain. Anti-cancer drugs such as loperamide and doxorubicin bound to nanomaterials have been shown to cross the intact blood-brain barrier and released at therapeutic concentrations in the brain. The use of nanomaterials including peptide-based nanotubes to target the vascular endothelial growth factor (VEGF) receptor and cell adhesion molecules like integrins, cadherins and selectins, is a new approach to control disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
Freitas, S., Merkle, H. P., & Gander, B. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.015 · Cited by 923
Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801 · cited 1×
“Many investigators have found that nanoparticles hold promise for ferrying such agents into the brain [20-22].”
Fonseca, C., Simões, S., & Gaspar, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00212-2 · Cited by 755
RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System
Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Glud, S. Z., Andersen, M. Ø., Hovgaard, M. B., Schmitz, A., Nyengaard, J. R., Besenbacher, F., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.04.010 · Cited by 585
A reevaluation of integrins as regulators of angiogenesis
Hynes, R. O. (2002) · Nature Medicine · doi:10.1038/nm0902-918 · Cited by 548
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery
Schreier, H., & Bouwstra, J. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90039-6 · Cited by 532
The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs
KIPP, J. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.07.019 · Cited by 529
The Evolution of Cell Adhesion
Hynes, R. O., & Zhao, Q. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.2.f89 · Cited by 487
YOSHIOKA, T., STERNBERG, B., & FLORENCE, A. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90228-3 · Cited by 475
The preparation and properties of niosomes—non-ionic surfactant vesicles
Baillie, A. J., Florence, A. T., Hume, L. R., Muirhead, G. T., & Rogerson, A. (1985) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1985.tb04990.x · Cited by 473
Platelet physiology and thrombosis
Andrews, R. K., & Berndt, M. C. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.07.020 · Cited by 445
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, S. E., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434
Yusuf‐Makagiansar, H., Anderson, M. E., Yakovleva, T. V., Murray, J. S., & Siahaan, T. J. (2002) · Medicinal Research Reviews · doi:10.1002/med.10001 · Cited by 408
Helical Rosette Nanotubes: Design, Self-Assembly, and Characterization
Fenniri, H., Mathivanan, P., Vidale, K. L., Sherman, D. M., Hallenga, K., Wood, K. V., & Stowell, J. G. (2001) · Journal of the American Chemical Society · doi:10.1021/ja005886l · Cited by 389
Self-citationAdhesion, migration and communication in melanocytes and melanoma
Haass, N. K., Smalley, K. S. M., Li, L., & Herlyn, M. (2005) · Pigment Cell Research · doi:10.1111/j.1600-0749.2005.00235.x · Cited by 388
In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin–PLGA conjugates
Yoo, H. S., Lee, K. H., Oh, J. E., & Park, T. G. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00280-7 · Cited by 374
A Death-Promoting Role for Extracellular Signal-Regulated Kinase
Zhuang, S., & Schnellmann, R. G. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107367 · Cited by 355
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
Schiffelers, R. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00240-2 · Cited by 310
Michaelis, K., Hoffmann, M. M., Dreis, S., Herbert, E., Alyautdin, R. N., Michaelis, M., Kreuter, J., & Langer, K. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097139 · Cited by 303
Paclitaxel nanoparticles for the potential treatment of brain tumors
Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.006 · Cited by 299
Proniosomes: A Novel Drug Carrier Preparation
Hu, C., & Rhodes, D. G. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00122-2 · Cited by 298
Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference
Tan, W. B., Jiang, S., & Zhang, Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.018 · Cited by 295
Niosomes as carriers for tretinoin
Manconi, M., Sinico, C., Valenti, D., Lai, F., & Fadda, A. M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.045 · Cited by 267
Chen, X., Plasencia, C., Hou, Y., & Neamati, N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049165z · Cited by 256
Nanomedicine for respiratory diseases
Pison, U., Welte, T., Giersig, M., & Groneberg, D. A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.068 · Cited by 255
Christofori, G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg228 · Cited by 254
Dispersions of lamellar phases of non‐ionic lipids in cosmetic products
HANDJANI‐VILA, R. M., RIBIER, A., RONDOT, B., & VANLERBERGHIE, G. (1979) · International Journal of Cosmetic Science · doi:10.1111/j.1467-2494.1979.tb00224.x · Cited by 251
Drug targeting with nano-sized carrier systems
Yokoyama, M. (2005) · Journal of Artificial Organs · doi:10.1007/s10047-005-0285-0 · Cited by 232
Peptide-derivatized biodegradable nanoparticles able to cross the blood–brain barrier
Costantino, L., Gandolfi, F., Tosi, G., Rivasi, F., Vandelli, M. A., & Forni, F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.013 · Cited by 208
PAOLINO, D., COSCO, D., MUZZALUPO, R., TRAPASSO, E., PICCI, N., & FRESTA, M. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.037 · Cited by 207
Panyam, J., & Labhasetwar, V. (2004) · Molecular Pharmaceutics · doi:10.1021/mp034002c · Cited by 195
Park, J. H., Kwon, S., Nam, J.-O., Park, R.-W., Chung, H., Seo, S. B., Kim, I.-S., Kwon, I. C., & Jeong, S. Y. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.020 · Cited by 190
Quantum dots to monitor RNAi delivery and improve gene silencing
Chen, A. A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni188 · Cited by 186
Alexa Fluor 488 as an iron sensing molecule and its application in PEBBLE nanosensors
Sumner, J. P., & Kopelman, R. (2005) · The Analyst · doi:10.1039/b414189j · Cited by 176
Kersten, G. F. A., & Crommelin, D. T. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00540-6 · Cited by 173
Entropically driven self-assembly of multichannel rosette nanotubes
Fenniri, H., Deng, B.-L., Ribbe, A. E., Hallenga, K., Jacob, J., & Thiyagarajan, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032527099 · Cited by 170
Self-citationLi, L., Wartchow, C. A., Danthi, S. N., Shen, Z., Dechene, N., Pease, J., Choi, H. S., Doede, T., Chu, P., Ning, S., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.10.057 · Cited by 161
In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors
Koziara, J. M., Whisman, T. R., Tseng, M. T., & Mumper, R. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.001 · Cited by 158
Cell Adhesion Molecules for Targeted Drug Delivery
Dunehoo, A. L., Anderson, M. E., Majumdar, S., Kobayashi, N., Berkland, C. J., & Siahaan, T. J. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20676 · Cited by 144
Anderson, M. E., & Siahaan, T. J. (2003) · Peptides · doi:10.1016/s0196-9781(03)00083-4 · Cited by 139
A Review on Applications of Liposomes in Textile Processing
Barani, H., & Montazer, M. (2008) · Journal of Liposome Research · doi:10.1080/08982100802354665 · Cited by 115
Zhang, Y., Sun, C., Kohler, N., & Zhang, M. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000013363.77466.63 · Cited by 105
Ould-Ouali, L., Noppe, M., Langlois, X., Willems, B., Riele, P. T., Timmerman, P., Brewster, M. E., Ariën, A., & Véronique Préat, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.022 · Cited by 98
Epigenetic events in the colorectum and in colon cancer
Grady, W. M. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330684 · Cited by 97
Groneberg, D. A., Rabe, K. F., & Fischer, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.055 · Cited by 93
RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system
Gupta, A. S., Huang, G., Lestini, B. J., Sagnella, S. M., Kottke‐Marchant, K., & Marchant, R. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-06-0340 · Cited by 82
Balland, O., Pinto‐Alphandary, H., Viron, A., Puvion, E., Andremont, A., & Couvreur, P. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.1.105 · Cited by 66
Gaspar, R. S., Véronique Préat, A., Opperdoes, F. R., & Roland, M. (1992) · Pharmaceutical Research · doi:10.1023/a:1015807706530 · Cited by 64
Delivering cancer stem cell therapies – A role for nanomedicines?
Schätzlein, A. G. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.044 · Cited by 46
Therapeutic Antagonists and the Conformational Regulation of the β2 Integrins
Shimaoka, M., & Springer, T. A. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387575 · Cited by 44
Cited by
Antibacterial properties of nanoparticles
Hajipour, M. J., Fromm, K. M., Akbar Ashkarran, A., Jimenez de Aberasturi, D., Larramendi, I. R. D., Rojo, T., Serpooshan, V., Parak, W. J., & Mahmoudi, M. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.06.004 · Cited by 2,710
Huh, A. J., & Kwon, Y. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.002 · Cited by 1,864
Albumin-based nanoparticles as potential controlled release drug delivery systems
Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.031 · Cited by 1,520
Nanoparticles as drug delivery systems
Wilczewska, A. Z., Niemirowicz, K., Markiewicz, K. H., & Car, H. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70901-5 · Cited by 1,445
Batrakova, E. V., & Kabanov, A. V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.013 · Cited by 1,278
Metadata
- Authors
- Suri, S. S., Fenniri, H., & Singh, B.
- Venue
- Journal of Occupational Medicine and Toxicology
- Published
- 2007-12
- Volume
- 2
- Issue
- 1
- Pages
- 16-16
- ISSN
- 1745-6673 (ISSN-L)
- OpenAlex
- W2139169365
- Cited by
- 755
- References
- 53
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.